ADMA Biologics Inc (ADMA)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 331,410 318,193 303,691 276,419 257,013 273,699 266,243 264,086 270,402 224,095 222,774 239,800 208,729 174,785 171,355 177,277 153,741 139,549 142,990 165,488
Total current liabilities US$ in thousands 55,542 44,891 44,177 53,088 49,806 41,841 41,952 36,728 39,267 44,440 28,072 31,567 30,378 32,337 18,186 21,206 19,947 16,474 12,880 13,908
Current ratio 5.97 7.09 6.87 5.21 5.16 6.54 6.35 7.19 6.89 5.04 7.94 7.60 6.87 5.41 9.42 8.36 7.71 8.47 11.10 11.90

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $331,410K ÷ $55,542K
= 5.97

The current ratio of ADMA Biologics Inc has fluctuated over the past few years, indicating changes in the company's liquidity position. The current ratio measures the company's ability to cover its short-term liabilities with its short-term assets. ADMA Biologics Inc experienced a significant decline in its current ratio from a high of 11.90 on March 31, 2020, to a low of 5.04 on September 30, 2022, before gradually improving to 7.09 on September 30, 2024.

A current ratio above 1 indicates that a company can cover its short-term obligations with its current assets. Therefore, ADMA Biologics Inc has generally maintained a current ratio above 1 throughout the period, suggesting that the company has had sufficient current assets to meet its short-term liabilities.

However, a declining current ratio over time could signal potential liquidity challenges or inefficiencies in managing current assets and liabilities. Investors and creditors may view a decreasing current ratio with caution, as it may indicate a weakening financial position. It is important for ADMA Biologics Inc to continue monitoring its current ratio and implement strategies to maintain a healthy liquidity position.